XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -33 | -43 | -33 |
EBITDA | -1,460 | -820 | -883 |
EBIT | -1,493 | -863 | -917 |
Net Income | 170 | -3,018 | 2,699 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -745 | -1,306 | -1,307 |
Cash | 3,078 | 3,835 | 3,447 |
Basic Shares | 2,429 | 2,429 | 2,205 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -141 | -75 | -17 | -20 |
EBITDA | -4,870 | -9,410 | -1,628 | -1,250 |
EBIT | -5,012 | -9,485 | -1,646 | -1,271 |
Net Income | -2,152 | -6,988 | -1,295 | -1,284 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,629 | -8,862 | -4,786 | -742 |
Cash | 3,447 | 10,407 | 14,785 | 171 |
Basic Shares | 1,981 | 1,479 | 1,090 | 740 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.20 |
2024-06-30 | $0.05 |
2024-03-31 | $1.35 |
2023-09-30 | -$0.67 |
